Recent Progress in Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors for the Treatment of Parkinson’s Disease

Recent Progress in Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors for the Treatment of Parkinson’s Disease

Williamson, D. S. et al., In Medicinal Chemistry Reviews; Bronson, J. J., Ed., 2018, ACS MEDI, Vol. 53, Ch. 5, pp 67–78

< Back to all news